Polymorphism in human cytomegalovirus UL40 impacts on recognition of human leukocyte antigen-E (HLA-E) by natural killer cells

Journal of Biological Chemistry

Volumn 288, Issue 12, 2013, Pages 8679-8690

  Heatley, Susan L ^a   Pietra, Gabriella ^b   Lin, Jie ^a   Widjaja, Jacqueline M L ^a   Harpur, Christopher M ^a   Lester, Sue ^c   Rossjohn, Jamie ^d   Szer, Jeff ^e   Schwarer, Anthony ^f   Bradstock, Kenneth ^g   Bardy, Peter G ^h   Mingari, Maria Cristina ^b,i   Moretta, Lorenzo ^j   Sullivan, Lucy C ^a   Brooks, Andrew G ^a  

^a UNIVERSITY OF MELBOURNE   (Australia)

^b UNIVERSITY OF GENOA   (Italy)

^c QUEEN ELIZABETH HOSPITAL   (Australia)

^d MONASH UNIVERSITY   (Australia)

^e ROYAL MELBOURNE HOSPITAL   (Australia)

^f ALFRED HOSPITAL   (Australia)

^g WESTMEAD HOSPITAL   (Australia)

^h ROYAL ADELAIDE HOSPITAL   (Australia)

ⁱ UNIVERSITY OF GENOA   (Italy)

^j G GASLINI INSTITUTE   (Italy)

more..

Author keywords

[No Author keywords available]

Indexed keywords

HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMAN CYTOMEGALOVIRUS; HUMAN LEUKOCYTE ANTIGEN; HUMAN LEUKOCYTES; IMMUNOMODULATORY; IMMUNOSURVEILLANCE; LEADER SEQUENCE; NATURAL KILLER CELLS;

ANTIGENS; CELLS; MOLECULES; PEPTIDES;

CYTOLOGY;

CD94 ANTIGEN; HLA E ANTIGEN; NATURAL KILLER CELL RECEPTOR NKG2A;

ADULT; ANTIGEN RECOGNITION; ARTICLE; CONTROLLED STUDY; FEMALE; GENE INTERACTION; GENETIC POLYMORPHISM; GENETIC VARIABILITY; GRAFT RECIPIENT; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMAN; HUMAN CELL; HUMAN CYTOMEGALOVIRUS; IMMUNOREGULATION; LYMPHOCYTE CLONE; LYMPHOCYTE FUNCTION; MAJOR CLINICAL STUDY; MALE; NATURAL KILLER CELL; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; UL40 GENE; VIRUS CELL INTERACTION; VIRUS GENE;

ADULT; AMINO ACID SEQUENCE; BINDING SITES; CELLS, CULTURED; CYTOMEGALOVIRUS; CYTOTOXICITY, IMMUNOLOGIC; FEMALE; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HISTOCOMPATIBILITY ANTIGENS CLASS I; HUMANS; KILLER CELLS, NATURAL; LEUKEMIA, MYELOID, ACUTE; LYMPHOMA, NON-HODGKIN; MALE; MIDDLE AGED; MOLECULAR SEQUENCE DATA; NK CELL LECTIN-LIKE RECEPTOR SUBFAMILY C; NK CELL LECTIN-LIKE RECEPTOR SUBFAMILY D; PHYLOGENY; POLYMORPHISM, GENETIC; PROTEIN BINDING; SEQUENCE ANALYSIS, DNA; VIRAL PROTEINS; YOUNG ADULT;

CYTOMEGALOVIRUS; HUMAN HERPESVIRUS 5;

EID: 84875438461     PISSN: 00219258     EISSN: 1083351X     Source Type: Journal    
DOI: 10.1074/jbc.M112.409672     Document Type: Article

References (36)

1. Moretta, L., Bottino, C., Pende, D., Castriconi, R., Mingari, M. C., and Moretta, A. (2006) Surface NK receptors and their ligands on tumor cells. Semin. Immunol. 18, 151-158 (Pubitemid 43817561)
2. Brostjan, C., Bellón, T., Sobanov, Y., López-Botet, M., and Hofer, E. (2002) Differential expression of inhibitory and activating CD94/NKG2 receptors on NK cell clones. J. Immunol. Methods 264, 109-119 (Pubitemid 34615897)
3. Braud, V. M., Allan, D. S., O'Callaghan, C. A., Söderström, K., D'Andrea, A., Ogg, G. S., Lazetic, S., Young, N. T., Bell, J. I., Phillips, J. H., Lanier, L. L., and McMichael, A. J. (1998) HLA-E binds to natural killer cell receptors CD94/NKG2A, -B, and -C. Nature 391, 795-799 (Pubitemid 28099678)
4. Brooks, A. G., Borrego, F., Posch, P. E., Patamawenu, A., Scorzelli, C. J., Ulbrecht, M., Weiss, E. H., and Coligan, J. E. (1999) Specific recognition of HLA-E, but not classical, HLA class I molecules by soluble CD94/NKG2A and NK cells. J. Immunol. 162, 305-313 (Pubitemid 29018934)
5. Braud, V. M., Allan, D. S., Wilson, D., and McMichael, A. J. (1998) TAPand tapasin-dependent HLA-E surface expression correlates with the binding of an MHC class I leader peptide. Curr. Biol. 8, 1-10 (Pubitemid 28056248)
6. O'Callaghan, C. A., Tormo, J., Willcox, B. E., Braud, V. M., Jakobsen, B. K., Stuart, D. I., McMichael, A. J., Bell, J. I., and Jones, E. Y. (1998) Structural features impose tight peptide binding specificity in the nonclassical MHC molecule HLA-E. Mol. Cell 1, 531-541 (Pubitemid 128374689)
7. Bland, F. A., Lemberg, M. K., McMichael, A. J., Martoglio, B., and Braud, V. M. (2003) Requirement of the proteasome for the trimming of signal peptide-derived epitopes presented by the nonclassical major histocompatibility complex class I molecule HLA-E. J. Biol. Chem. 278, 33747-33752 (Pubitemid 37553208)
8. Gumá, M., Budt, M., Sáez, A., Brckalo, T., Hengel, H., Angulo, A., and López-Botet, M. (2006) Expansion of CD94/NKG2C- NK cells in response to human cytomegalovirus-infected fibroblasts. Blood 107, 3624-3631
9. Söderberg-Nauclér, C., Fish, K. N., and Nelson, J. A. (1997) Reactivation of latent human cytomegalovirus by allogeneic stimulation of blood cells from healthy donors. Cell 91, 119-126 (Pubitemid 27431318)
10. Yewdell, J. W., and Hill, A. B. (2002) Viral interference with antigen presentation. Nat. Immunol. 3, 1019-1025 (Pubitemid 35363652)
11. Wilkinson, G. W., Tomasec, P., Stanton, R. J., Armstrong, M., Prod'homme, V., Aicheler, R., McSharry, B. P., Rickards, C. R., Cochrane, D., Llewellyn-Lacey, S., Wang, E. C., Griffin, C. A., and Davison, A. J. (2008) Modulation of natural killer cells by human cytomegalovirus. J. Clin. Virol. 41, 206-212
12. Tomasec, P., Braud, V. M., Rickards, C., Powell, M. B., McSharry, B. P., Gadola, S., Cerundolo, V., Borysiewicz, L. K., McMichael, A. J., and Wilkinson, G. W. (2000) Surface expression of HLA-E, an inhibitor of natural killer cells, enhanced by human cytomegalovirus gpUL40. Science 287, 1031
13. Ulbrecht, M., Martinozzi, S., Grzeschik, M., Hengel, H., Ellwart, J. W., Pla, M., and Weiss, E. H. (2000) Cutting edge: the human cytomegalovirus UL40 gene product contains a ligand for HLA-E and prevents NK cellmediated lysis. J. Immunol. 164, 5019-5022 (Pubitemid 30305172)
14. Wang, E. C., McSharry, B., Retiere, C., Tomasec, P., Williams, S., Borysiewicz, L. K., Braud, V. M., and Wilkinson, G. W. (2002) UL40-mediatedNK evasion during productive infection with human cytomegalovirus. Proc. Natl. Acad. Sci. U.S.A. 99, 7570-7575 (Pubitemid 34568732)
15. Kaiser, B. K., Barahmand-Pour, F., Paulsene, W., Medley, S., Geraghty, D. E., and Strong, R. K. (2005) Interactions between NKG2x immunoreceptors and HLA-E ligands display overlapping affinities and thermodynamics. J. Immunol. 174, 2878-2884 (Pubitemid 40279705)
16. Miller, J. D., Weber, D. A., Ibegbu, C., Pohl, J., Altman, J. D., and Jensen, P. E. (2003) Analysis of HLA-E peptide binding specificity and contact residues in bound peptide required for recognition by CD94/NKG2. J. Immunol. 171, 1369-1375 (Pubitemid 36900069)
17. Sullivan, L. C., Clements, C. S., Beddoe, T., Johnson, D., Hoare, H. L., Lin, J., Huyton, T., Hopkins, E. J., Reid, H. H., Wilce, M. C., Kabat, J., Borrego, F., Coligan, J. E., Rossjohn, J., and Brooks, A. G. (2007) The heterodimeric assembly of the CD94-NKG2 receptor family and implications for human leukocyte antigen-E recognition. Immunity 27, 900-911 (Pubitemid 50013980)
18. Valés-Gómez, M., Reyburn, H. T., Erskine, R. A., López-Botet, M., and Strominger, J. L. (1999) Kinetics and peptide dependency of the binding of the inhibitory NK receptor CD94/NKG2-A and the activating receptor CD94/NKG2-C to HLA-E. EMBO J. 18, 4250-4260 (Pubitemid 29364127)
19. Petrie, E. J., Clements, C. S., Lin, J., Sullivan, L. C., Johnson, D., Huyton, T., Heroux, A., Hoare, H. L., Beddoe, T., Reid, H. H., Wilce, M. C., Brooks, A. G., and Rossjohn, J. (2008) CD94-NKG2A recognition of human leukocyte antigen (HLA)-E bound to an HLA class I leader sequence. J. Exp. Med. 205, 725-735 (Pubitemid 351439316)
20. Hoare, H. L., Sullivan, L. C., Clements, C. S., Ely, L. K., Beddoe, T., Henderson, K. N., Lin, J., Reid, H. H., Brooks, A. G., and Rossjohn, J. (2008) Subtle changes in peptide conformation profoundly affect recognition of the nonclassical MHC class I molecule HLA-E by the CD94-NKG2 natural killer cell receptors. J. Mol. Biol. 377, 1297-1303
21. Cerboni, C., Mousavi-Jazi, M., Wakiguchi, H., Carbone, E., Kärre, K., and Söderström, K. (2001) Synergistic effect of IFN- and human cytomegalovirus protein UL40 in the HLA-E-dependent protection from NK cellmediated cytotoxicity. Eur. J. Immunol. 31, 2926-2935
22. Garrigue, I., Corte, M. F., Magnin, N., Couzi, L., Capdepont, S., Rio, C., Merville, P., Dechanet-Merville, J., Fleury, H., and Lafon, M. E. (2007) Variability of UL18, UL40, UL111a, and US3 immunomodulatory genes among human cytomegalovirus clinical isolates from renal transplant recipients. J. Clin. Virol. 40, 120-128 (Pubitemid 47432859)
23. Garrigue, I., Faure-Della Corte, M., Magnin, N., Recordon-Pinson, P., Couzi, L., Lebrette, M. E., Schrive, M. H., Roncin, L., Taupin, J. L., Déchanet- Merville, J., Fleury, H., and Lafon, M. E. (2008) UL40 human cytomegalovirus variability evolution patterns over time in renal transplant recipients. Transplantation 86, 826-835
24. Magri, G., Muntasell, A., Romo, N., Sáez-Borderías, A., Pende, D., Geraghty, D. E., Hengel, H., Angulo, A., Moretta, A., and López-Botet, M. (2011) NKp46 and DNAM-1 NK-cell receptors drive the response to human cytomegalovirus-infected myeloid dendritic cells overcoming viral immune evasion strategies. Blood 117, 848-856
25. Prod'homme, V., Tomasec, P., Cunningham, C., Lemberg, M. K., Stanton, R. J., McSharry, B. P., Wang, E. C., Cuff, S., Martoglio, B., Davison, A. J., Braud, V. M., and Wilkinson, G. W. (2012) Human cytomegalovirus UL40 signal peptide regulates cell surface expression of the NK cell ligands HLA-E and gpUL18. J. Immunol. 188, 2794-2804
26. Page, R. D. (1996) TreeView: an application to display phylogenetic trees on personal computers. Comput. Appl. Biosci. 12, 357-358
27. Carretero, M., Cantoni, C., Bellón, T., Bottino, C., Biassoni, R., Rodríguez, A., Pérez-Villar, J. J., Moretta, L., Moretta, A., and López-Botet, M. (1997) The CD94 and NKG2-A C-type lectins covalently assemble to form a natural killer cell inhibitory receptor for HLA class I molecules. Eur. J. Immunol. 27, 563-567 (Pubitemid 27085264)
28. Borrego, F., Ulbrecht, M., Weiss, E. H., Coligan, J. E., and Brooks, A. G. (1998) Recognition of human histocompatibility leukocyte antigen (HLA)-E complexed with HLA class I signal sequence-derived peptides by CD94/NKG2 confers protection from natural killer cell-mediated lysis. J. Exp. Med. 187, 813-818 (Pubitemid 28115198)
29. Poggi, A., Biassoni, R., Pella, N., Paolieri, F., Bellomo, R., Bertolini, A., Moretta, L., and Mingari, M. C. (1990) In vitro expansion of CD3/TCRhuman thymocyte populations that selectively lack CD3 delta gene expression: a phenotypic and functional analysis. J. Exp. Med. 172, 1409-1418 (Pubitemid 20366216)
30. Miyasaka, T., Takeshima, S. N., Jimba, M., Matsumoto, Y., Kobayashi, N., Matsuhashi, T., Sentsui, H., and Aida, Y. (2013) Identification of bovine leukocyte antigen class II haplotypes associated with variations in bovine leukemia virus proviral load in Japanese Black cattle. Tissue Antigens 81, 72-82
31. Miyasaka, T., Takeshima, S. N., Matsumoto, Y., Kobayashi, N., Matsuhashi, T., Miyazaki, Y., Tanabe, Y., Ishibashi, K., Sentsui, H., and Aida, Y. (2011) The diversity of bovineMHCclass II DRB3 and DQA1 alleles in different herds of Japanese Black and Holstein cattle in Japan. Gene 472, 42-49
32. von Heijne, G. (1983) Patterns of amino acids near signal-sequence cleavage sites. Eur. J. Biochem. 133, 17-21
33. Strong, R. K., Holmes, M. A., Li, P., Braun, L., Lee, N., and Geraghty, D. E. (2003) HLA-E allelic variants. Correlating differential expression, peptide affinities, crystal structures, and thermal stabilities. J. Biol. Chem. 278, 5082-5090 (Pubitemid 36801018)
34. Valés-Gómez, M., Reyburn, H., and Strominger, J. (2000) Molecular analyses of the interactions between human NK receptors and their HLA ligands. Hum. Immunol. 61, 28-38 (Pubitemid 30058764)
35. Llano, M., Lee, N., Navarro, F., García, P., Albar, J. P., Geraghty, D. E., and López-Botet, M. (1998) HLA-E-bound peptides influence recognition by inhibitory and triggering CD94/NKG2 receptors: preferential response to an HLA-G-derived nonamer. Eur. J. Immunol. 28, 2854-2863 (Pubitemid 28425243)
36. Faure-Della Corte, M., Samot, J., Garrigue, I., Magnin, N., Reigadas, S., Couzi, L., Dromer, C., Velly, J. F., Déchanet-Merville, J., Fleury, H. J., and Lafon, M. E. (2010) Variability and recombination of clinical human cytomegalovirus strains from transplantation recipients. J. Clin. Virol. 47, 161-169